Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

survival analysis

  • You have access
    Preoperative Vertebral Fracture: A Prognostic Factor in Stage I-III Colorectal Cancer
    TEPPEI KAMADA, KENEI FURUKAWA, JUNJI TAKAHASHI, TAKASHI AIDA, KEIGO NAKASHIMA, EISAKU ITO, NORIHIKO SUZUKI, TAIGO HATA, HIRONORI OHDAIRA, KEN ETO, TORU IKEGAMI and YUTAKA SUZUKI
    Anticancer Research August 2024, 44 (8) 3533-3541; DOI: https://doi.org/10.21873/anticanres.17174
  • Open Access
    An Overview of Introductory and Advanced Survival Analysis Methods in Clinical Applications: Where Have we Come so far?
    GEORGIOS BEIS, AGGELOS ILIOPOULOS and IOANNIS PAPASOTIRIOU
    Anticancer Research February 2024, 44 (2) 471-487; DOI: https://doi.org/10.21873/anticanres.16835
  • You have access
    Time on Treatment and Survival Outcomes for Patients Treated With First-line Osimertinib vs. Other Tyrosine Kinase Inhibitors, for EGFR Mutation-positive Metastatic Non-small Cell Lung Cancer: Real-world Experience Data
    SARAH SHARMAN MOSER, LIOR APTER, JOSIE SOLOMON, GABRIEL CHODICK, MIRIANA WOLLNER and NAVA SIEGELMANN-DANIELI
    Anticancer Research January 2024, 44 (1) 257-265; DOI: https://doi.org/10.21873/anticanres.16809
  • Open Access
    Prognostic Role of Porphyromonas gingivalis Gingipain Rgp and Matrix Metalloproteinase 9 in Oropharyngeal Squamous Cell Carcinoma
    ANNA KAISA KYLMÄ, TIMO SORSA, LAURI JOUHI, HARRI K. MUSTONEN, HESHAM MOHAMED, REIJA RANDÉN-BRADY, ANTTI MÄKITIE, TIMO ATULA, JAANA HAGSTRÖM and CAJ HAGLUND
    Anticancer Research November 2022, 42 (11) 5415-5430; DOI: https://doi.org/10.21873/anticanres.16046
  • You have access
    Prognostic Role of Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 in Stage IV Colorectal Cancer
    HIDETAKA KAWAMURA, MICHITAKA HONDA, YOSHINAO TAKANO, SHUNJI KINUTA, TAKAHIRO KAMIGA, SHIGEHIRA SAJI and KOJI KONO
    Anticancer Research August 2022, 42 (8) 3921-3928; DOI: https://doi.org/10.21873/anticanres.15886
  • You have access
    Clinical Impact of Primary Tumor Site in Stage IV Colorectal Cancer: A Statewide Cohort Study
    HIDETAKA KAWAMURA, MICHITAKA HONDA, KOICHI TAKIGUCHI, TAKAHIRO KAMIGA, KATSUMASA SAITO, ATSUSHI MUTO, SATORU SHIRASO, NAOYUKI YAMASHITA, TOSHIYASU IWAO, SHIGEHIRA SAJI, KOJI KONO and SHINICHI KONNO
    Anticancer Research November 2021, 41 (11) 5693-5702; DOI: https://doi.org/10.21873/anticanres.15385
  • You have access
    Rediscussing the Role of Traditional Risk Factors in Young Adults With Oral Squamous Cell Carcinoma
    NORBERT NECKEL, MARCO MICHAEL, DANIEL TROELTZSCH, JONAS WÜSTER, STEFFEN KOERDT, CHRISTIAN DOLL, KORINNA JÖHRENS, KONRAD NEUMANN, MAX HEILAND and JAN-DIRK RAGUSE
    Anticancer Research December 2020, 40 (12) 6987-6995; DOI: https://doi.org/10.21873/anticanres.14723
  • You have access
    LRRC17 Is Linked to Prognosis of Ovarian Cancer Through a p53-dependent Anti-apoptotic Function
    CHANG-KYU OH, JEONG JUN PARK, MIHYANG HA, HYE JIN HEO, JUNHO KANG, EUN JUNG KWON, JI WAN KANG, YOUNGJOO KIM, JIN MO KANG, SEUNG ZHOO YOON, YEJI KO, DAI SIK KO and YUN HAK KIM
    Anticancer Research October 2020, 40 (10) 5601-5609; DOI: https://doi.org/10.21873/anticanres.14573
  • You have access
    Overall Survival of Patients With Locoregional and Metastatic Breast Cancer: Is the Influence of Baseline Characteristics the Same?
    INÊS GOMES, PEDRO AGUIAR, ANA MIRANDA and CARLA NUNES
    Anticancer Research September 2019, 39 (9) 5135-5142; DOI: https://doi.org/10.21873/anticanres.13708
  • You have access
    The Prognostic Role of Cancer Stem Cell Markers for Long-term Outcome After Resection of Colonic Liver Metastases
    LIDEWIJ SPELT, AGATA SASOR, DANIEL ANSARI, KATARZYNA SAID HILMERSSON and ROLAND ANDERSSON
    Anticancer Research January 2018, 38 (1) 313-320;

Pages

  • Next
  • 1
  • 2
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire